🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCardiovascular OutcomesSOUL trial preliminary data — what worked for you? Page 2

SOUL trial preliminary data — what worked for you?

Dr.KarenChen Thu, May 16, 2024 at 2:46 PM 13 replies 2,080 viewsPage 2 of 3
TirzTom
Senior Member
2,789
9,876
Feb 2024
Florida
Online
May 17, 2024 at 1:31 AM#6
Dr.ReproEndo said:
Relative and absolute effects need reading together.

Pushing back on Dr.ReproEndo here. I would add the less popular caveat: these trial populations under-represented several groups, older adults and the highest BMI categories among them. The results probably generalise, and "probably" should be stated as an assumption rather than dropped.

Last edited: May 17, 2024 at 5:31 AM
31 1josh_phd_bmore, roxy_nash, tony_orlando and 28 others
Reply Quote Save Share Report
hank_denver
Member
278
1,234
Sep 2024
Denver, CO
May 17, 2024 at 5:46 AM#7
Dr.KarenChen said:
I keep finding that the number in the press summary and the number in the paper are not the same number, and the difference is always in the same…

Bayesian meta-analysis perspective on the trial evidence: traditional frequentist meta-analyses report point estimates and confidence intervals. Bayesian approaches provide probability distributions that are more intuitive for clinical decision-making.

For example: "There is a 98.5% probability that semaglutide 2.4mg produces >10% weight loss vs placebo" is more actionable than "RR 3.4, 95% CI 2.8-4.1, p<0.001."

The the trial evidence evidence is strong under both frameworks, but Bayesian analysis better communicates the degree of certainty for individual patient counseling.

Last edited: May 17, 2024 at 9:46 AM
30 0raj_cambridge, ingrid_STO, pete_nash and 27 others
Reply Quote Save Share Report
VendorMark
Senior Member
3,456
14,567
Jan 2024
Texas
Online
May 17, 2024 at 10:01 AM#8
TirzTom said:
I would add the less popular caveat: these trial populations under-represented several groups, older adults and the highest BMI categories among them.

Forest plot interpretation for the the trial evidence meta-analysis: when reading the pooled estimate, pay attention to:

  1. Point estimate (HR/RR/OR) — center of the diamond
  2. Confidence interval width — precision of the estimate
  3. I² statistic — heterogeneity across studies
  4. Individual study weights — are results driven by one large trial?
  5. Prediction interval — range of plausible true effects in future settings

The the trial evidence meta-analysis shows a pooled RR of 0.78 (95% CI 0.66-0.83), I²=51%. This is a robust and consistent effect.

29 24MarkLI_maint, Dr.PeteFamMed, claudia_zurich and 26 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides

GL Biochem (Shanghai) Ltd. — Direct Manufacturer

Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.

Browse GL Biochem
amy_econ_NJ
Member
567
2,567
May 2024
Princeton, NJ
May 17, 2024 at 2:16 PM#9

A narrower follow-up, since the general answer is now clear:

What did you change at the same time, and can you separate the two now?

Last edited: May 17, 2024 at 5:16 PM
28 23gary_naperville, sean_dublin, hannah_MT and 25 others
Reply Quote Save Share Report
Dr.KarenChen
VIP Member
4,210
24,567
Nov 2023
San Francisco, CA
May 18, 2024 at 10:41 AM#10

Closing the loop on my own question.

Update — my curve sits below the published mean and the explanation is that the trial arm had support I do not have. That was reassuring rather than otherwise.

10 8sarah_nash92, FitDadDave, RunnerRach and 7 others
Reply Quote Save Share Report

Similar Threads

SELECT trial: 20% MACE reduction — mechanistic deep dive7 replies
Semaglutide cardiovascular benefit independent of weight loss11 replies
STEP-HFpEF: semaglutide in heart failure with preserved EF15 replies
GLP-1 and arterial inflammation — hsCRP and IL-6 reduction data18 replies
Lp(a) on GLP-1 agonists — any impact on this risk factor?8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register